MARIELA NIEVES-RODRIGUEZ, M.D.
Endocrinology, Diabetes & Metabolism Physician in BAYAMON, Puerto Rico. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARIELA NIEVES-RODRIGUEZ, M.D. filed 5,256 Medicare Part D claims in 2023 as a Endocrinology, Diabetes & Metabolism Physician in BAYAMON, Puerto Rico, prescribing 41% generic.
- 5K
- Part D claims, 2023
- 41%
- generic prescribing
- $331.32
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARIELA NIEVES-RODRIGUEZ, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
5,256 Top 6% higher than 94% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
MARIELA NIEVES-RODRIGUEZ, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MARIELA NIEVES-RODRIGUEZ, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Puerto Rico
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Puerto Rico providers
Endocrinology, Diabetes & Metabolism Physician share within Puerto Rico
Endocrinology, Diabetes & Metabolism Physician is one of the more visible NUCC categories in Puerto Rico
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Endocrinology, Diabetes & Metabolism Physician ABMS/AOA estimate
Est. board-certified rate (Endocrinology, Diabetes & Metabolism Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
Specialty board-certified rate — Endocrinology, Diabetes & Metabolism Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARIELA NIEVES-RODRIGUEZ, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 77 CALLE SANTA CRUZ, BAYAMON, PR, 00961, with a listed phone of (787) 300-2815. NPI 1376747766 was issued on 06/12/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what NIEVES-RODRIGUEZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,256 prescription claims written by this provider, covering 425 Medicare beneficiaries and totaling roughly $1.3 million in drug spend, split 59% brand-name and 41% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1376747766 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 06/12/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARIELA NIEVES-RODRIGUEZ, M.D.'s current license status, disciplinary history, and board certifications directly with the licensing state's medical board before relying on this page for a clinical or care decision.
How we sourced this profile
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARIELA NIEVES-RODRIGUEZ, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$331
Largest payer
Boehringer Ingelheim Pharmaceuticals, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
59% brand-name claims vs 41% generic, on 5,256 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 7,678
- Total Day Supply
- 228,703
- Brand vs Generic
- 59% brand / 41% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $28K
Patient Demographics
- Average Patient Age
- 69.7 years
- Avg HCC Risk Score
- 1.97
- Gender Split
- 72% female / 28% male
- Age Distribution
- <65: 90, 65-74: 216, 75-84: 102, 85+: 17
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARIELA NIEVES-RODRIGUEZ, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Synthroid
Synthroid
1,188 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
527 claims
- Metformin Hcl 271
Metformin Hcl
271 claims
- Ezetimibe 165
Ezetimibe
165 claims
- Trulicity 152
Trulicity
152 claims
- Xigduo Xr 150
Xigduo Xr
150 claims
- Glimepiride 144
Glimepiride
144 claims
- Synjardy Xr 130
Synjardy Xr
130 claims
| Drug | Claims |
|---|---|
| Synthroid Levothyroxine Sodium | 1,188 |
| Rosuvastatin Calcium | 527 |
| Metformin Hcl | 271 |
| Ezetimibe | 165 |
| Trulicity Dulaglutide | 152 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 150 |
| Glimepiride | 144 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 130 |
| Atorvastatin Calcium | 112 |
| Janumet Sitagliptin Phos/Metformin Hcl | 112 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How MARIELA NIEVES-RODRIGUEZ, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
MARIELA NIEVES-RODRIGUEZ, M.D.'s 5,256 claims are above the specialty average of 2,639.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Puerto Rico
Other clinicians with the same primary specialty enrolled in Puerto Rico, drawn from the same CMS NPPES roster as NIEVES-RODRIGUEZ.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Puerto Rico
Frequently Asked Questions
What is MARIELA NIEVES-RODRIGUEZ, M.D.'s specialty? ▼
How much does MARIELA NIEVES-RODRIGUEZ, M.D. prescribe under Medicare Part D? ▼
Where is MARIELA NIEVES-RODRIGUEZ, M.D. located? ▼
What is MARIELA NIEVES-RODRIGUEZ, M.D.'s NPI number? ▼
Does MARIELA NIEVES-RODRIGUEZ, M.D. prescribe more brand-name or generic drugs? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does MARIELA NIEVES-RODRIGUEZ, M.D. prescribe most often? ▼
Does MARIELA NIEVES-RODRIGUEZ, M.D. accept Medicare? ▼
How can I verify MARIELA NIEVES-RODRIGUEZ, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology